Radiation therapy regulates TCF-1 to maintain CD8+T cell stemness and promotes anti-tumor immunotherapy

被引:9
|
作者
Wang, Bin [1 ]
Hu, Jing [1 ]
Zhang, Jian [2 ]
Zhao, Lina [1 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Radiat Oncol, 15 West Changle Rd, Xian 710032, Peoples R China
[2] Air Force Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China
关键词
Radiotherapy; TCF-1; Stem CD8+T; cGAS; STING; TME; CD8(+) T-CELLS; RADIOTHERAPY; MICROENVIRONMENT; IMMUNITY; TRIAL;
D O I
10.1016/j.intimp.2022.108646
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Radiotherapy is a very effective cancer treatment, mainly through inducing DNA damage of cancer cells. Meanwhile, there is evidence that irradiation can also mobilize tumor-specific immunity, and recent investigations demonstrate that the efficiency of local high-dose radiotherapy is attributable to the presence of CD8+T cells. Here, we observed that high-dose radiation remarkably increased the enrichment of stem cell-like CD8+T cells. Moreover, cGAS/STING signaling augmented stem cell-like CD8+T cells and T stem-like central memory CD8+T cells in a mice tumor model after radiation. These findings raise our understanding of stem celllike CD8+T cells after radiation stimulation and improve radiation therapy by driving the cGAS/STING signaling pathway for cancer multimodality therapy.
引用
收藏
页数:6
相关论文
共 46 条
  • [31] Altered CD8+ T-Cell Lymphocyte Function and TC1 Cell Stemness Contribute to Enhanced Malignant Tumor Properties in Murine Models of Sleep Apnea
    Akbarpour, Mahzad
    Khalyfa, Abdelnaby
    Qiao, Zhuanghong
    Gileles-Hillel, Alex
    Almendros, Isaac
    Farre, Ramon
    Gozal, David
    SLEEP, 2017, 40 (02)
  • [32] Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy
    Lester, Daniel K.
    Burton, Chase
    Gardner, Alycia
    Innamarato, Patrick
    Kodumudi, Krithika
    Liu, Qian
    Adhikari, Emma
    Ming, Qianqian
    Williamson, Daniel B.
    Frederick, Dennie T.
    Sharova, Tatyana
    White, Michael G.
    Markowitz, Joseph
    Cao, Biwei
    Nguyen, Jonathan
    Johnson, Joseph
    Beatty, Matthew
    Mockabee-Macias, Andrea
    Mercurio, Matthew
    Watson, Gregory
    Chen, Pei-Ling
    McCarthy, Susan
    MoranSegura, Carlos
    Messina, Jane
    Thomas, Kerry L.
    Darville, Lancia
    Izumi, Victoria
    Koomen, John M.
    Pilon-Thomas, Shari A.
    Ruffell, Brian
    Luca, Vincent C.
    Haltiwanger, Robert S.
    Wang, Xuefeng
    Wargo, Jennifer A.
    Boland, Genevieve M.
    Lau, Eric K.
    NATURE CANCER, 2023, 4 (02) : 222 - +
  • [33] TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming
    Lee, Junseok
    Im, Keon-Il
    Gil, Sojin
    Na, Hyemin
    Min, Gi-June
    Kim, Nayoun
    Cho, Seok-Goo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (06)
  • [34] DPP inhibition alters the CXCR3 axis and enhances NK and CD8+T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
    Fitzgerald, Allison A.
    Wang, Shangzi
    Agarwal, Veena
    Marcisak, Emily F.
    Zuo, Annie
    Jablonski, Sandra A.
    Loth, Melanie
    Fertig, Elana J.
    MacDougall, John
    Zhukovsky, Eugene
    Trivedi, Shubhendu
    Bhatia, Dimple
    O'Neill, Vince
    Weiner, Louis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [35] A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells
    Chang, Yao-Wen
    Hsiao, Huey-Wen
    Chen, Ju-Pei
    Tzeng, Sheue-Fen
    Tsai, Chin-Hsien
    Wu, Chun-Yi
    Hsieh, Hsin-Hua
    Carmona, Santiago J.
    Andreatta, Massimo
    Di Conza, Giusy
    Su, Mei-Tzu
    Koni, Pandelakis A.
    Ho, Ping-Chih
    Chen, Hung-Kai
    Yang, Muh-Hwa
    CELL REPORTS MEDICINE, 2023, 4 (08)
  • [36] Increased CD3+T cells with a low FOXP3+/CD8+T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients
    Kim, Hyojin
    Kwon, Hyun Jung
    Han, Yeon Bi
    Park, Soo Young
    Kim, Eun Sun
    Kim, Se Hyun
    Kim, Yu Jung
    Lee, Jong Seok
    Chung, Jin-Haeng
    MODERN PATHOLOGY, 2019, 32 (03) : 367 - 375
  • [37] Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
    Ruggiu, Mathilde
    Guerin, Marion V.
    Corre, Beatrice
    Bardou, Margot
    Alonso, Ruby
    Russo, Erica
    Garcia, Zacarias
    Feldmann, Lea
    Lemaitre, Fabrice
    Dusseaux, Mathilde
    Grandjean, Capucine L.
    Bousso, Philippe
    JOURNAL OF EXPERIMENTAL MEDICINE, 2024, 221 (04):
  • [38] Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
    Peng, David H.
    Rodriguez, Bertha Leticia
    Diao, Lixia
    Chen, Limo
    Wang, Jing
    Byers, Lauren A.
    Wei, Ying
    Chapman, Harold A.
    Yamauchi, Mitsuo
    Behrens, Carmen
    Raso, Gabriela
    Soto, Luisa Maren Solis
    Cuentes, Edwin Roger Parra
    Wistuba, Ignacio I.
    Kurie, Jonathan M.
    Gibbons, Don L.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [39] Proliferative exhausted CD8+ T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma
    Cheng, Danni
    Qiu, Ke
    Rao, Yufang
    Mao, Minzi
    Li, Li
    Wang, Yan
    Song, Yao
    Chen, Junren
    Yi, Xiaowei
    Shao, Xiuli
    Huang, Shao Hui
    Zhang, Yi
    Chen, Xuemei
    Wu, Sisi
    Yu, Shuaishuai
    Liu, Jun
    Wang, Haiyang
    Peng, Xingchen
    Li, Daibo
    Yang, Lin
    Chen, Li
    Ying, Zhiye
    Zheng, Yongbo
    Zheng, Meijun
    Ying, Binwu
    Zeng, Xiaoxi
    Zhang, Wei
    Xu, Wei
    Liu, Geoffrey
    Chen, Fei
    Yu, Haopeng
    Zhao, Yu
    Ren, Jianjun
    ELIFE, 2023, 12
  • [40] In situ anti-tumor immunization using the tumor microenvironment reprograming with a TLR4-agonist induces strong CD4 and CD8 T cells responses, long-living T cell memory, and protection against 4T1 metastatic breast cancer in mice
    Ushakova, E.
    Savchenko, M.
    Lebedeva, E.
    Pichugin, A.
    Ataullakhanov, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 391 - 391